DHJJ Financial Advisors’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
– Sell
-6
Closed -$822 – 979
2025
Q1
$822 Sell
6
-6
-50% -$858 ﹤0.01% 709
2024
Q4
$1.84K Sell
12
-6
-33% -$1.01K ﹤0.01% 613
2024
Q3
$3.49K Sell
18
-5
-22% -$1.05K ﹤0.01% 565
2024
Q2
$5.33K Sell
23
-1
-4% -$217 ﹤0.01% 505
2024
Q1
$5.18K Hold
24
– – ﹤0.01% 498
2023
Q4
$6.21K Hold
24
– – ﹤0.01% 478
2023
Q3
$6.17K Buy
+24
New +$6.42K ﹤0.01% 475

Other funds holding BIIB

DHJJ Financial Advisors's BIIB Position: Q2 2025 in Review

DHJJ Financial Advisors sold out of Biogen (BIIB) in Q2 2025, closing a stake of 6 shares — an estimated $822 sold.

DHJJ Financial Advisors first reported a position in BIIB in Q3 2023 and held it in 7 quarters. The position peaked at $6.21K in Q4 2023. 866 funds tracked by Wall St. Rank hold BIIB as of Q2 2025.

  • DHJJ Financial Advisors reported no remaining Biogen position as of Q2 2025 after selling out during the quarter.
  • DHJJ Financial Advisors sold 6 Biogen shares in Q2 2025, an estimated $822.
  • DHJJ Financial Advisors first reported a position in Biogen in Q3 2023 and held it in 7 quarters.
  • DHJJ Financial Advisors's Biogen position peaked at $6.21K in Q4 2023.
  • 866 funds tracked by Wall St. Rank held Biogen as of Q2 2025.

Based on DHJJ Financial Advisors's 13F filing for Q2 2025, filed 21 Jul 2025.